U.S. Representatives Urge FDA to Reconsider Menthol Ban

Regulations by 2FIRSTS.ai
Jun.27.2023
U.S. Representatives Urge FDA to Reconsider Menthol Ban
US congressmen urge FDA to reconsider the proposed ban on menthol cigarettes and flavored cigars to prevent illegal trade.

According to a report by CSPdailynews, 20 members of the United States Congress have written to the Commissioner of the Food and Drug Administration (FDA), Robert Califf, stating that banning menthol cigarettes and flavored cigars will exacerbate the issue of illegal trade in tobacco products.

 

The FDA is expected to formally release the final regulations for new tobacco standards in August, however, the ban will not take effect for at least one year.

 

The letter stated that:

 

When Congress created the Tobacco Control Act in 2009, the intention was to enable the FDA to regulate the tobacco industry properly. If the ban were to result in a large illegal market, it would only increase the risk to the American people, lead to more crime, burden law enforcement agencies, and create more community conflict.

 

Lawmakers urged the FDA in a letter to take illegal markets seriously. The letter referenced that the FDA could meet the needs of adult consumers through regulatory measures and establish control measures to protect children from harm caused by these products.

 

We urge you to reconsider the proposed regulations by the FDA on menthol cigarettes and flavored cigars and to avoid further prohibitive actions that may fuel the expansion of the illegal market.

 

Previously, Califf admitted at a hearing of the House Agriculture, Rural Development, and FDA Appropriations Subcommittee that the FDA is unable to eliminate illegal e-cigarette products from the market.

 

Despite the FDA's efforts to regulate e-cigarette products since 2016, they have failed to bring order to this category. With a few exceptions, the majority of adult consumers' needs have not been met.

 

In April of this year, the Food and Drug Administration (FDA) submitted a status report on the progress of Pre-Market Tobacco Product Applications (PMTAs), stating that the review process is expected to be completed by the end of this year.

 

The agency has issued 45 marketing authorizations (MGOs) for tobacco products that have gone through the PMTA process, but no marketing authorizations have been issued for any other flavored products besides tobacco.

 

The letter states that the ban on menthol cigarettes will prevent approximately one-third of all cigarettes currently sold in the United States from entering into the legal and regulated distribution system. Lawmakers are concerned that this ban could lead to an illegal market similar to e-cigarette products, further increasing the burden on law enforcement.

 

The letter also mentions examples from Massachusetts and California, where the illegal tobacco market has continued to grow after the ban on flavored tobacco sales. The letter states that a large illegal e-cigarette market has now developed throughout the United States.

 

The letter stated that these e-cigarette products were smuggled illegally through the US borders and ports, sold in violation of state and local criminal laws, and sold without age verification procedures in place.

 

As of now, the FDA has not responded to the evaluation request from CSP.

 

Reference:

 

Congress members are urging the Food and Drug Administration (FDA) to review their proposal to ban menthol cigarettes in the United States.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
China Council for the Promotion of International Trade (CCPIT) held its July regular press conference on July 31, 2026, releasing the May 2026 Global Economic and Trade Friction Index. CCPIT spokesperson Yang Fan said the global trade friction index stood at 95 in May, remaining at a medium-to-high level. By industry, the electronics sector recorded the highest trade friction index among 13 monitored industries. In China-related trade frictions, the index stood at 93, with electronics products including drones, chips and vape products among areas where friction remained elevated.
Aug.03
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07